-
1دورية أكاديميةRANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer
المؤلفون: Marina Ciscar, Eva M Trinidad, Gema Perez‐Chacon, Mansour Alsaleem, Maria Jimenez, Maria J Jimenez‐Santos, Hector Perez‐Montoyo, Adrian Sanz‐Moreno, Andrea Vethencourt, Michael Toss, Anna Petit, Maria T Soler‐Monso, Victor Lopez, Jorge Gomez‐Miragaya, Clara Gomez‐Aleza, Lacey E Dobrolecki, Michael T Lewis, Alejandra Bruna, Silvana Mouron, Miguel Quintela‐Fandino, Fatima Al‐Shahrour, Antonio Martinez‐Aranda, Angels Sierra, Andrew R Green, Emad Rakha, Eva Gonzalez‐Suarez
المصدر: EMBO Molecular Medicine, Vol 15, Iss 4, Pp n/a-n/a (2023)
مصطلحات موضوعية: breast cancer patient‐derived xenografts, ER negative breast cancer, menopause, pharmacological RANKL inhibitors, RANK‐RANKL, Medicine (General), R5-920, Genetics, QH426-470
وصف الملف: electronic resource
-
2دورية أكاديميةRANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer
المؤلفون: Ciscar, Marina, Trinidad, Eva M., Perez-Chacon, Gema, Alsaleem, Mansour, Jimenez, Maria, Jimenez-Santos, Maria J, Perez-Montoyo, Hector, Sanz-Moreno, Adrian, Vethencourt, Andrea, Toss, Michael, Petit, Anna, Soler-Monso, Maria T, Lopez, Victor, Gomez-Miragaya, Jorge, Gomez-Aleza, Clara, Dobrolecki, Lacey E., Lewis, Michael T., Bruna, Alejandra, Mouron, Silvana, Quintela-Fandino, Miguel, Al-Shahrour, Fatima, Martinez-Aranda, Antonio, Sierra, Angels, Green, Andrew R., Rakha, Emad, Gonzalez-Suarez, Eva
مصطلحات موضوعية: Breast cancer patient-derived xenografts, ER negative breast cancer, menopause, pharmacological RANKL inhibitors, RANK-RANKL, Nottingham Breast Cancer Research Centre
العلاقة: https://nottingham-repository.worktribe.com/output/18236709Test; EMBO Molecular Medicine; Volume 15; Issue 4; https://nottingham-repository.worktribe.com/file/18236709/1/EMBO%20Mol%20Med%20-%202023%20-%20Ciscar%20-%20RANK%20is%20a%20poor%20prognosis%20marker%20and%20a%20therapeutic%20target%20in%20ER%E2%80%90negative%20postmenopausalTest
الإتاحة: https://doi.org/10.15252/emmm.202216715Test
https://nottingham-repository.worktribe.com/file/18236709/1/EMBO%20Mol%20Med%20-%202023%20-%20Ciscar%20-%20RANK%20is%20a%20poor%20prognosis%20marker%20and%20a%20therapeutic%20target%20in%20ER%E2%80%90negative%20postmenopausalTest
https://nottingham-repository.worktribe.com/output/18236709Test -
3دورية أكاديمية
المؤلفون: Georgia Melagraki, Evangelos Ntougkos, Dimitra Papadopoulou, Vagelis Rinotas, Georgios Leonis, Eleni Douni, Antreas Afantitis, George Kollias
المصدر: Frontiers in Pharmacology, Vol 9 (2018)
مصطلحات موضوعية: direct TNF inhibitors, RANKL inhibitors, natural products, autoimmune diseases, virtual screening, molecular dynamics, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/article/10.3389/fphar.2018.00800/fullTest; https://doaj.org/toc/1663-9812Test
-
4دورية أكاديمية
المؤلفون: Nardone, Valeria, D'Asta, Federica, Brandi, Maria Luisa
المصدر: Clinics. June 2014 69(6)
مصطلحات موضوعية: Antiresorptive Drugs, Bone Formation, Osteoblasts, Osteogenesis, RANKL Inhibitors
وصف الملف: text/html
-
5دورية أكاديمية
المؤلفون: Valeria Nardone, Federica D'Asta, Maria Luisa Brandi
المصدر: Clinics, Vol 69, Iss 6, Pp 438-446 (2014)
مصطلحات موضوعية: Antiresorptive Drugs, Bone Formation, Osteoblasts, Osteogenesis, RANKL Inhibitors, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000600438&lng=en&tlng=enTest; https://doaj.org/toc/1980-5322Test
-
6
المؤلفون: Georgia Melagraki, Evangelos Ntougkos, Dimitra Papadopoulou, Vagelis Rinotas, Georgios Leonis, Eleni Douni, Antreas Afantitis, George Kollias
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, direct TNF inhibitors, RANKL inhibitors, natural products, autoimmune diseases, virtual screening, molecular dynamics
الإتاحة: https://doi.org/10.3389/fphar.2018.00800.s001Test
https://figshare.com/articles/dataset/Data_Sheet_1_In_Silico_Discovery_of_Plant-Origin_Natural_Product_Inhibitors_of_Tumor_Necrosis_Factor_TNF_and_Receptor_Activator_of_NF-_B_Ligand_RANKL_docx/6859316Test -
7
المؤلفون: Federica D’Asta, Maria Luisa Brandi, Valeria Nardone
المصدر: Clinics; v. 69 n. 6 (2014); 438-446
Clinics; Vol. 69 Núm. 6 (2014); 438-446
Clinics; Vol. 69 No. 6 (2014); 438-446
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Volume: 69, Issue: 6, Pages: 438-446, Published: JUN 2014
Clinics, Vol 69, Iss 6, Pp 438-446 (2014)مصطلحات موضوعية: Male, Selective Estrogen Receptor Modulators, musculoskeletal diseases, medicine.medical_specialty, Osteoporosis, Thiophenes, Review, Bone tissue, Antibodies, Monoclonal, Humanized, Bone resorption, Bone remodeling, Strontium ranelate, Osteogenesis, Internal medicine, Teriparatide, Bone cell, medicine, Antiresorptive Drugs, Humans, RANKL Inhibitors, osteogenesis, Pharmacological management, lcsh:R5-920, Osteoblasts, Bone Density Conservation Agents, Diphosphonates, business.industry, Bone Formation, General Medicine, medicine.disease, Endocrinology, Denosumab, medicine.anatomical_structure, Cancer research, Female, Bone Diseases, lcsh:Medicine (General), business, medicine.drug
وصف الملف: application/pdf; text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea37287899f5ed5f1145b8b3b19e7fe5Test
http://hdl.handle.net/2158/874522Test